| Ms Fran Brazzell, OT | |
|
4551 E Camino Pimeria Alta, Tucson, AZ 85718-3548 | |
| (520) 243-0212 | |
| Not Available |
| Full Name | Ms Fran Brazzell |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 4551 E Camino Pimeria Alta, Tucson, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891837191 | NPI | - | NPPES |
| 103105 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0463 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Fran Brazzell, OT 4551 E Camino Pimeria Alta, Tucson, AZ 85718-3548 Ph: (520) 243-0212 | Ms Fran Brazzell, OT 4551 E Camino Pimeria Alta, Tucson, AZ 85718-3548 Ph: (520) 243-0212 |
News Archive
A new report shows that the percentage of girls who experience a major depressive episode in the past year triples between the ages of 12 and 15 (from 5.1 percent to 15.2 percent respectively). The report by the Substance Abuse and Mental Health Services Administration (SAMHSA) also shows that an annual average of 1.4 million adolescent girls age 12 to 17 experienced a major depressive episode in the past year.
Avanir Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Actavis South Atlantic LLC and Actavis, Inc. (collectively, "Actavis") to resolve pending patent litigation in response to Actavis' abbreviated new drug application seeking approval to market generic versions of Avanir's NUEDEXTA (dextromethorphan hydrobromide/quinidine sulfate) capsules.
The Associated Press reports that, across party lines, positions on new revenue as well as changes to Medicare and other entitlement programs are clouding the outlook for success. Meanwhile, The Medicare NewsGroup examines how certain Medicare proposals are playing
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
› Verified 1 days ago
Teresa Ramona Karjalainen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 720-404-0816 | |
Ashley Rae Holten, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2002 S Kelvin Stra, Tucson, AZ 85713 Phone: 719-304-1256 | |
Michael Cauble, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 6231 N Montebella Rd, Tucson, AZ 85704 Phone: 520-500-8348 | |
Mrs. Susan L. Johnson Lucht, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Danielle Marie Stradling, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 916-220-0518 | |
Graciela Contreras, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 520-225-6000 | |
Gail Abbey, O.T. Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2500 N Rosemont Blvd, Tucson, AZ 85712 Phone: 520-325-4800 |